DK569687D0 - IFOSPHAMIDE LYPHILIZATE AND PROCEDURE FOR ITS PREPARATION - Google Patents

IFOSPHAMIDE LYPHILIZATE AND PROCEDURE FOR ITS PREPARATION

Info

Publication number
DK569687D0
DK569687D0 DK569687A DK569687A DK569687D0 DK 569687 D0 DK569687 D0 DK 569687D0 DK 569687 A DK569687 A DK 569687A DK 569687 A DK569687 A DK 569687A DK 569687 D0 DK569687 D0 DK 569687D0
Authority
DK
Denmark
Prior art keywords
lyphilizate
ifosphamide
procedure
preparation
ifosfamide
Prior art date
Application number
DK569687A
Other languages
Danish (da)
Other versions
DK169308B1 (en
DK569687A (en
Inventor
Dieter Sauerbier
Uwe-Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of DK569687D0 publication Critical patent/DK569687D0/en
Publication of DK569687A publication Critical patent/DK569687A/en
Application granted granted Critical
Publication of DK169308B1 publication Critical patent/DK169308B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

1. A lyophilized preparation consisting of ifosfamide and 0.1 to 17 parts by weight hexitol per part by weight ifosfamide and, optionally, other standard pharmaceutical auxiliaries.
DK569687A 1986-10-31 1987-10-30 Lyophilized preparation, process for preparing an ifosfamide lyophilizate preparation and the ifosfamide lyophilizate preparation obtained by the method DK169308B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31
DE3637089 1986-10-31

Publications (3)

Publication Number Publication Date
DK569687D0 true DK569687D0 (en) 1987-10-30
DK569687A DK569687A (en) 1988-05-01
DK169308B1 DK169308B1 (en) 1994-10-10

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569687A DK169308B1 (en) 1986-10-31 1987-10-30 Lyophilized preparation, process for preparing an ifosfamide lyophilizate preparation and the ifosfamide lyophilizate preparation obtained by the method

Country Status (25)

Country Link
EP (1) EP0265812B1 (en)
JP (1) JPS63159319A (en)
KR (1) KR900003491B1 (en)
AT (1) ATE55250T1 (en)
AU (1) AU598602B2 (en)
CA (1) CA1314231C (en)
DD (1) DD262582A5 (en)
DE (1) DE3764235D1 (en)
DK (1) DK169308B1 (en)
EG (1) EG18333A (en)
ES (1) ES2017982B3 (en)
FI (1) FI87140C (en)
GE (1) GEP19971025B (en)
GR (1) GR3000708T3 (en)
HU (1) HU197987B (en)
IL (1) IL84312A (en)
IN (1) IN168119B (en)
LV (1) LV10051B (en)
MX (1) MX8958A (en)
NO (1) NO873860L (en)
PT (1) PT86032B (en)
RU (1) RU1836079C (en)
UA (1) UA11075A (en)
YU (1) YU197387A (en)
ZA (1) ZA878183B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE65402T1 (en) * 1988-03-19 1991-08-15 Asta Pharma Ag IFOSFAMIDE MESNA LYOPHILISATE AND PROCESS FOR PRODUCTION THEREOF.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (en) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamide lyophilizate preparations
ID27487A (en) * 1998-03-03 2001-04-12 Shionolog & Co Ltd PHARMACEUTICAL COMPOSITION THAT CONTAINS NATRIUM PHOSPHOLIPASE (3- (2-AMINO-1,2-DIOXOETHYL) -2-ETHYL-1-PHENYLMETHYL) 1H-INDOL-4) OCCETIC ACETATE
AU2003276689B2 (en) * 2002-09-05 2009-04-09 Bharat Serums And Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
MXPA05005919A (en) * 2002-12-02 2005-09-21 Bharat Serums & Vaccines Ltd Ifosfamide compositions for parenteral administration and a process for their preparation.
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
DK2071917T3 (en) * 2006-09-29 2013-03-04 Infa Sa Packaging system for pharmaceutical compositions and kits for intravenous administration
WO2016087001A1 (en) * 2014-12-04 2016-06-09 Huawei Technologies Co., Ltd. Load allocation in a data communication network

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (en) * 1977-05-09 1978-11-16 Walton J Smith Anhydrous compsn. prodn. by freeze drying hydrated, hydrolysable prod. - esp. aspirin or aspirin salt solns.
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
DK169308B1 (en) 1994-10-10
IN168119B (en) 1991-02-09
GEP19971025B (en) 1997-04-06
FI87140B (en) 1992-08-31
KR900003491B1 (en) 1990-05-21
ATE55250T1 (en) 1990-08-15
IL84312A0 (en) 1988-03-31
JPS63159319A (en) 1988-07-02
EP0265812B1 (en) 1990-08-08
IL84312A (en) 1991-11-21
LV10051B (en) 1995-06-20
DD262582A5 (en) 1988-12-07
EP0265812A1 (en) 1988-05-04
FI87140C (en) 1992-12-10
LV10051A (en) 1994-05-10
GR3000708T3 (en) 1991-10-10
EG18333A (en) 1993-12-30
FI874727A0 (en) 1987-10-27
DK569687A (en) 1988-05-01
HUT44932A (en) 1988-05-30
HU197987B (en) 1989-07-28
YU197387A (en) 1988-12-31
AU598602B2 (en) 1990-06-28
ZA878183B (en) 1988-05-02
NO873860D0 (en) 1987-09-15
KR880004814A (en) 1988-06-27
ES2017982B3 (en) 1991-03-16
MX8958A (en) 1993-12-01
FI874727A (en) 1988-05-01
NO873860L (en) 1988-05-02
PT86032B (en) 1990-08-31
AU8052987A (en) 1988-05-05
CA1314231C (en) 1993-03-09
RU1836079C (en) 1993-08-23
JPH0543684B2 (en) 1993-07-02
DE3764235D1 (en) 1990-09-13
PT86032A (en) 1987-11-01
UA11075A (en) 1996-12-25

Similar Documents

Publication Publication Date Title
NO900528L (en) ANTHELMINTICS, PROCEDURE FOR PREPARING THEREOF, AND PREPARATION WITH A CONTENT THEREOF.
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
PT90030A (en) PROCESS FOR THE PREPARATION OF IFOSPHAMIDE AND MESNA LYOPHYLISATE
NO890259L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ETHYLPHENOXYACETAMIDES.
ES557153A0 (en) A PROCEDURE FOR PREPARING LAUDANS
DK569687A (en) IFOSPHAMIDE LYPHILIZATE AND PROCEDURE FOR ITS PREPARATION
NO880473L (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES AND THEIR USE AS A MEDICINE.
NO169721C (en) DISUBSTITUTED N, N'-BIS-MALEIMIDES AND PROCEDURES FOR THEIR PREPARATION
DK103987A (en) SUBSTITUTED 1,3,4,9-TETRAHYDROPYRANOE3,4-BAAINDOL-L-ACETIC ACIDS, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
NO871481D0 (en) SUBSTITUTED THIACYCLOALKENO (3,2-B) PYRIDINES AND PROCEDURES FOR THEIR PREPARATION.
NZ219623A (en) N-(heterocyclic-substituted phenyl)-n'-benzoylurea derivatives and pesticidal compositions
KR900700484A (en) Aminopropanol derivative of 1,4: 3,6-dianhydro hexitol salate, its preparation and use as a medicament
DK164906C (en) ISOTHIOUR INGREDIENT DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
DK574588A (en) PHARMACEUTICALS FOR HUMAN AND ANIMALS WITH ANTIVIRAL AND ANTITUMORAL EFFECTS AND PROCEDURES FOR PRODUCING THEREOF
NO880639D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXIMETERS OF 2,6-DIOKSABICYCLO (3, 3, 0) OCTANONS.
IT8821003A0 (en) PROCEDURE FOR THE PREPARATION OF "ALFA /4(1,1 DIMETHYLETHYL)PHENYL/ 4 (HYDROXYDIPHENYLMETHYL)1PIPERIDINBUTANOL".
NO164539C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-NAFTHYL-2,4-DIMETHYL-3H-1,2,4-TRIAZOL-3-THION.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired